Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
01 1PCAS Ecully FR
02 1MENADIONA, S.L. Palafolls ES
01 2Clomifene citrate
01 1France
02 1Spain
01 1Suspended by EDQM GMP non-compliance
02 1Valid
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
Certificate Number : R1-CEP 2003-251 - Rev 06
Status : Valid
Issue Date : 2022-02-09
Type : Chemical
Substance Number : 997
Certificate Number : R1-CEP 2003-193 - Rev 04
Status : Suspended by EDQM GMP non-compliance
Issue Date : 2020-08-07
Type : Chemical
Substance Number : 997
A Enclomiphene Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Enclomiphene Citrate, including repackagers and relabelers. The FDA regulates Enclomiphene Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Enclomiphene Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Enclomiphene Citrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Enclomiphene Citrate supplier is an individual or a company that provides Enclomiphene Citrate active pharmaceutical ingredient (API) or Enclomiphene Citrate finished formulations upon request. The Enclomiphene Citrate suppliers may include Enclomiphene Citrate API manufacturers, exporters, distributors and traders.
click here to find a list of Enclomiphene Citrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Enclomiphene Citrate CEP of the European Pharmacopoeia monograph is often referred to as a Enclomiphene Citrate Certificate of Suitability (COS). The purpose of a Enclomiphene Citrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Enclomiphene Citrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Enclomiphene Citrate to their clients by showing that a Enclomiphene Citrate CEP has been issued for it. The manufacturer submits a Enclomiphene Citrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Enclomiphene Citrate CEP holder for the record. Additionally, the data presented in the Enclomiphene Citrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Enclomiphene Citrate DMF.
A Enclomiphene Citrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Enclomiphene Citrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Enclomiphene Citrate suppliers with CEP (COS) on PharmaCompass.
LOOKING FOR A SUPPLIER?
